A Phase 3, Multi-Center, Randomized, Double-blind Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy” and identified as CY 6032

Disease Sites:

Not Available

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Brinkley, Douglas

Participating Institutions:

Vanderbilt University

Open Date:

10-09-2023

Trial Type:

Other

Protocol ID:

CRE-CHF0015

National Clinical Trial ID:

NCT05767346

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available